Skip to main content
. 2022 Jun 7;12:9373. doi: 10.1038/s41598-022-13465-x

Figure 3.

Figure 3

Persistence of treatment with antiosteoporosis medication over a 3-year follow-up in patients and controls. 100% of patients from FLS were recommended antiosteoporotic treatment. Edited with Microsoft 365 A3 for faculty.